Features | Partner Sites | Information | LinkXpress
Sign In
JIB
BioConferenceLive
GLOBETECH PUBLISHING

Different Bacteria Cultures Maintained in Microfluidic System

By BiotechDaily International staff writers
Posted on 13 Aug 2013
Image: Microfluidic system for multiple bacterial cultures (Photo courtesy of Polish Institute of Physical Chemistry).
Image: Microfluidic system for multiple bacterial cultures (Photo courtesy of Polish Institute of Physical Chemistry).
A fabricated microfluidic device allows hundreds of different bacteria cultures to be maintained simultaneously.

The system allows for the merging, transporting and splitting of microdroplets where strictly controlled chemical reactions and the cultivation of bacterial colonies can be performed.

A group of scientists at the Institute of Physical Chemistry (Warsaw, Poland) engineered the microfluidic systems from polymer plates that correspond to the size of a credit card. Inside the system, a carrier fluid, mostly oil, carries microdroplets containing chemicals, flows laminarly through tiny channels of diameters in the range of tenths or hundredths of a millimeter. In this single microfluidic system thousands of different chemical reactions can be carried out during a day.

The microsystem is composed of two branches of microchannels forming densely arranged zigzags. A few hundred droplets can circulate in the microchannels, at a distance of about one centimeter from each other. The microdroplets move in a pendular movement from one branch to the other. Each droplet circulating within the microfluidic system has its own unique identifier, assigned by the optoelectronic system. It allows the scientist to monitor at any time what operations have been carried out on each microdroplet. A single droplet can include over 100,000 bacteria that are unable to move between the droplets, as the bacteria cannot cross the surface membrane of a microdroplet, and the carrier liquid used to transport microdroplets is not an environment favorable for the life of bacteria.

Piotr Garstecki, PhD, DSc, the lead author, said, “We can transform each microdroplet into a real bioreactor. Therefore, in a single small plate we can have up to several hundreds of bioreactors, with different, controlled concentration of an antibiotic, a different antibiotic or even different bacterial species in each bioreactor.” The paper was published on July 15, 2013, in the journal Angewandte Chemie International Edition.

Related Links:

Polish Institute of Physical Chemistry



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Scanning electron micrograph of cultured human neuron from induced pluripotent stem cell (Photo courtesy of the University of California, San Diego).

Induced Stem Cells Show Genetic Abnormalities Not Found in Embryonic Stem Cells

All stem cells are not created equal: genomic evaluation revealed that the genome of stem cells generated from adult cells (induced pluripotent stem cells or iPS cells) differed considerably from that... Read more

Drug Discovery

view channel
Image: A mouse mammary gland missing the tumor-suppressor p53 shows expression of ARF (green), now known for a backup role in protecting cells from becoming cancerous. If both p53 and ARF are mutated, the tumors that form are aggressive and may benefit from treatment with anti-inflammatory drugs called JAK inhibitors, currently prescribed for rheumatoid arthritis (Photo courtesy of Raleigh Kladney).

Anti-Inflammatory Drugs May Treat Some Aggressive Rumors

New research raises the possibility that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis. By studying triple-negative... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.